XML 55 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands
6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities:    
Net income (loss) attributable to Nabors $ 275,273 $ 83,821
Adjustments to net income (loss):    
Depreciation and amortization 451,986 348,475
Depletion and other exploratory expenses 19,072 15,677
Deferred income tax expense (benefit) 47,308 (12,151)
Deferred financing costs amortization 2,922 2,559
Pension liability amortization and adjustments 300 199
Discount amortization on long-term debt 26,081 36,764
Amortization of loss on hedges 464 291
Losses (gains) on long-lived assets, net (41,458) 3,667
Losses (gains) on investments, net (8,761) 2,184
Losses (gains) on debt retirement, net 58 7,033
Losses (gains) on derivative instruments 338 1,580
Share-based compensation 8,107 7,047
Foreign currency transaction losses (gains), net 615 15,019
Equity in (earnings) losses of unconsolidated affiliates, net of dividends (102,122) (10,379)
Changes in operating assets and liabilities:    
Accounts receivable (82,533) (42,363)
Inventory (39,807) (7,308)
Other current assets 21,051 16,273
Other long-term assets 61,543 (11,765)
Trade accounts payable and accrued liabilities 237,743 15,025
Income taxes payable (13,363) (9,622)
Other long-term liabilities 5,085 7,883
Net cash provided by operating activities 869,902 469,909
Cash flows from investing activities:    
Purchases of investments (7,945) (27,988)
Sales and maturities of investments 20,622 27,997
Investment in unconsolidated affiliates (29,762) (10,936)
Distribution of proceeds from asset sales from unconsolidated affiliates 119,207  
Capital expenditures (1,003,245) (369,455)
Proceeds from sales of assets and insurance claims 102,067 17,567
Net cash used for investing activities (799,056) (362,815)
Cash flows from financing activities:    
Increase (decrease) in cash overdrafts 11,203 (6,130)
Proceeds from issuance of common shares 11,622 4,733
Proceeds from revolving credit facilities 1,200,000  
Debt issuance costs (2,188)  
Reduction in long-term debt (1,404,247) (273,605)
Repurchase of equity component of convertible debt (14) (4,712)
Settlement of call options and warrants, net   1,133
Purchase of restricted stock (2,527) (1,887)
Tax benefit related to share-based awards 42 (45)
Net cash used for financing activities (186,109) (280,513)
Effect of exchange rate changes on cash and cash equivalents 2,383 (6,803)
Net (decrease) increase in cash and cash equivalents (112,880) (180,222)
Cash and cash equivalents, beginning of period 641,702 927,815
Cash and cash equivalents, end of period $ 528,822 $ 747,593